Reciprocal regulation of miR-23a and lysophosphatidic acid receptor signaling in cardiomyocyte hypertrophy

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1831, Issue 8, 2013, Pages 1386-1394

  Yang, Jinjing ^a   Nie, Yu ^a   Wang, Fang ^a   Hou, Jianfeng ^a   Cong, Xiangfeng ^a   Hu, Shengshou ^a   Chen, Xi ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

(NRCMs); Cardiac hypertrophy; Cultured neonatal rat cardiomyocytes; Lysophosphatidic acid (LPA); MicroRNA (miRNA)

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID RECEPTOR; MICRORNA; MICRORNA 23A; PHOSPHATIDYLINOSITOL 3 KINASE; UNCLASSIFIED DRUG; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; CHROMONE DERIVATIVE; ENZYME INHIBITOR; LYSOPHOSPHOLIPID; MORPHOLINE DERIVATIVE; MUSCLE PROTEIN; PROTEIN KINASE B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURFACE; CONTROLLED STUDY; DOWN REGULATION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOMERE; UPREGULATION; WESTERN BLOTTING; ANIMAL; CARDIOMEGALY; CELL CULTURE; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; CARDIOMEGALY; CELLS, CULTURED; CHROMONES; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; HUMANS; LYSOPHOSPHOLIPIDS; MICRORNAS; MORPHOLINES; MUSCLE PROTEINS; MYOCYTES, CARDIAC; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, LYSOPHOSPHATIDIC ACID; SIGNAL TRANSDUCTION;

EID: 84882944649     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2013.05.005     Document Type: Article

References (39)

1. D.E. Manyari, Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study, N. Engl. J. Med. 323 (1990) 1706-1707.
2. J. Aoki, Two pathways for lysophosphatidic acid production, Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1781 (2008) 513-518.
3. J.H. Hecht, J.A. Weiner, S.R. Post, J. Chun, Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex, J. Cell Biol. 135 (1996) 1071-1083. (Pubitemid 26403779)
4. J.J. Contos, J. Chun, The mouse lp(A3)/Edg7 lysophosphatidic acid receptor gene: genomic structure, chromosomal localization, and expression pattern, Gene 267 (2001) 243-253. (Pubitemid 32324141)
5. J.J. Contos, J. Chun, Genomic characterization of the lysophosphatidic acid receptor gene, lp(A2)/Edg4, and identification of a frameshift mutation in a previously characterized cDNA, Genomics 64 (2000) 155-169. (Pubitemid 30191985)
6. T. Hla, M.J. Lee, N. Ancellin, J.H. Paik, M.J. Kluk, Lysophospholipids - receptor revelations, Science 294 (2001) 1875-1878. (Pubitemid 33101575)
7. G.B. Mills, W.H. Moolenaar, The emerging role of lysophosphatidic acid in cancer, Nat. Rev. Cancer 3 (2003) 582-591. (Pubitemid 37328830)
8. F.X. Yu, B. Zhao, N. Panupinthu, J.L. Jewell, I. Lian, L.H. Wang, J. Zhao, H. Yuan, K. Tumaneng, H. Li, X.D. Fu, G.B. Mills, K.L. Guan, Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling, Cell 150 (2012) 780-791.
9. M.E. Lin, D.R. Herr, J. Chun, Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance, Prostaglandins Other Lipid Mediat. 91 (2010) 130-138.
10. S.E. Gardell, A.E. Dubin, J. Chun, Emerging medicinal roles for lysophospholipid signaling, Trends Mol. Med. 12 (2006) 65-75. (Pubitemid 43202124)
11. X. Chen, X.Y. Yang, N.D. Wang, C. Ding, Y.J. Yang, Z.J. You, Q. Su, J.H. Chen, Serum lysophosphatidic acid concentrations measured by dot immunogold filtration assay in patients with acute myocardial infarction, Scand. J. Clin. Lab. Invest. 63 (2003) 497-504.
12. J. Chen, Y. Chen, W. Zhu, Y. Han, B. Han, R. Xu, L. Deng, Y. Cai, X. Cong, Y. Yang, S. Hu, X. Chen, Specific LPA receptor subtypemediation of LPA-induced hypertrophy of cardiacmyocytes and involvement of Akt and NFκB signal pathways, J. Cell. Biochem. 103 (2008) 1718-1731. (Pubitemid 351501905)
13. J. Chen, Y. Han, W. Zhu, R. Ma, B. Han, X. Cong, S. Hu, X. Chen, Specific receptor subtype mediation of LPA-induced dual effects in cardiac fibroblasts, FEBS Lett. 580 (2006) 4737-4745. (Pubitemid 44209256)
14. D.P. Bartel, MicroRNAs: genomics, biogenesis, mechanism, and function, Cell 116 (2004) 281-297.
15. E. van Rooij, L.B. Sutherland, N. Liu, A.H. Williams, J. McAnally, R.D. Gerard, J.A. Richardson, E.N. Olson, A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure, Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 18255-18260. (Pubitemid 44871645)
16. T. Thum, P. Galuppo, C. Wolf, J. Fiedler, S. Kneitz, L.W. van Laake, P.A. Doevendans, C.L. Mummery, J. Borlak, A. Haverich, C. Gross, S. Engelhardt, G. Ertl, J. Bauersachs, MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure, Circulation 116 (2007) 258-267. (Pubitemid 47196561)
17. A. Care, D. Catalucci, F. Felicetti, D. Bonci, A. Addario, P. Gallo, M.L. Bang, P. Segnalini, Y. Gu, N.D. Dalton, L. Elia, M.V. Latronico, M. Hoydal, C. Autore, M.A. Russo, G.W. Dorn 2nd, O. Ellingsen, P. Ruiz-Lozano, K.L. Peterson, C.M. Croce, C. Peschle, G. Condorelli, MicroRNA-133 controls cardiac hypertrophy, Nat. Med. 13 (2007) 613-618. (Pubitemid 46828487)
18. R.L. Montgomery, T.G. Hullinger, H.M. Semus, B.A. Dickinson, A.G. Seto, J.M. Lynch, C. Stack, P.A. Latimer, E.N. Olson, E. van Rooij, Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure, Circulation 124 (2011) 1537-1547.
19. Z. Lin, I. Murtaza, K. Wang, J. Jiao, J. Gao, P.F. Li, miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy, Proc. Natl. Acad. Sci. U.S.A. 106 (2009) 12103-12108.
20. X. Chen, Z. Cui, F. Zhang, W. Chang, L. Chen, L. Liu, Angiotensin II and cAMP regulate AT(1)-mRNA expression in rat cardiomyocytes by transcriptional mechanism, Eur. J. Pharmacol. 448 (2002) 1-9. (Pubitemid 34786715)
21. C. Chen, D.A. Ridzon, A.J. Broomer, Z. Zhou, D.H. Lee, J.T. Nguyen, M. Barbisin, N.L. Xu, V.R. Mahuvakar, M.R. Andersen, K.Q. Lao, K.J. Livak, K.J. Guegler, Real-time quantification of microRNAs by stem-loop RT-PCR, Nucleic Acids Res. 33 (2005) e179.
22. Y. Nie, B.M. Han, X.B. Liu, J.J. Yang, F. Wang, X.F. Cong, X. Chen, Identification of microRNAs involved in hypoxia- and serum deprivation-induced apoptosis in mesenchymal stem cells, Int. J. Biol. Sci. 7 (2011) 762-768.
23. Y. Hasegawa, J.R. Erickson, G.J. Goddard, S. Yu, S. Liu, K.W. Cheng, A. Eder, K. Bandoh, J. Aoki, R. Jarosz, A.D. Schrier, K.R. Lynch, G.B. Mills, X. Fang, Identification of a phosphothionate analogue of lysophosphatidic acid (LPA) as a selective agonist of the LPA3 receptor, J. Biol. Chem. 278 (2003) 11962-11969. (Pubitemid 36800170)
24. H. Ohta, K. Sato, N. Murata, A. Damirin, E. Malchinkhuu, J. Kon, T. Kimura, M. Tobo, Y. Yamazaki, T. Watanabe, M. Yagi, M. Sato, R. Suzuki, H. Murooka, T. Sakai, T. Nishitoba, D.S. Im, H. Nochi, K. Tamoto, H. Tomura, F. Okajima, Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors, Mol. Pharmacol. 64 (2003) 994-1005. (Pubitemid 37153068)
25. R.X. Xu, X. Chen, J.H. Chen, Y. Han, B.M. Han, Mesenchymal stem cells promote cardiomyocyte hypertrophy in vitro through hypoxia-induced paracrine mechanisms, Clin. Exp. Pharmacol. Physiol. 36 (2009) 176-180.
26. J.F. Chen, E.M. Mandel, J.M. Thomson, Q. Wu, T.E. Callis, S.M. Hammond, F.L. Conlon, D.Z. Wang, The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation, Nat. Genet. 38 (2006) 228-233. (Pubitemid 43177239)
27. J.W. Choi, D.R. Herr, K. Noguchi, Y.C. Yung, C.W. Lee, T. Mutoh, M.E. Lin, S.T. Teo, K.E. Park, A.N. Mosley, J. Chun, LPA receptors: subtypes and biological actions, Annu. Rev. Pharmacol. Toxicol. 50 (2010) 157-186.
28. T. Aoyagi, T. Matsui, Phosphoinositide-3 kinase signaling in cardiac hypertrophy and heart failure, Curr. Pharm. Des. 17 (2011) 1818-1824.
29. T. Matsui, T. Nagoshi, A. Rosenzweig, Akt and PI 3-kinase signaling in cardiomyocyte hypertrophy and survival, Cell Cycle 2 (2003) 220-223.
30. M. Kitayoshi, R. Fukui, E. Tanabe, K. Kato, K. Yoshikawa, N. Fukushima, T. Tsujiuchi, Different effects on cell proliferation and migration abilities of endothelial cells by LPA(1) and LPA(3) in mammary tumor FM3A cells, J. Recept. Signal Transduct. Res 32 (2012) 209-213.
31. K. Kato, K. Yoshikawa, E. Tanabe, M. Kitayoshi, R. Fukui, N. Fukushima, T. Tsujiuchi, Opposite roles of LPA(1) and LPA (3) on cellmotile and invasive activities of pancreatic cancer cells, Tumour Biol. 33 (2012) 1739-1744.
32. K. Wang, Z.Q. Lin, B. Long, J.H. Li, J. Zhou, P.F. Li, Cardiac hypertrophy is positively regulated by microRNA miR-23a, J. Biol. Chem. 287 (2012) 589-599.
33. A. Kalsotra, K. Wang, P.F. Li, T.A. Cooper, MicroRNAs coordinate an alternative splicing network during mouse postnatal heart development, Genes Dev. 24 (2010) 653-658.
34. Y.J. Xu, S.S. Rathi, M. Zhang, P. Bhugra, N.S. Dhalla, Mechanism of the positive inotropic effect of lysophosphatidic acid in rat heart, J. Cardiovasc. Pharmacol. Ther. 7 (2002) 109-115. (Pubitemid 34627482)
35. B. Cremers, M. Flesch, E. Kostenis, C. Maack, A. Niedernberg, A. Stoff, M. Sudkamp, O. Wendler, M. Bohm, Modulation of myocardial contractility by lysophosphatidic acid (LPA), J. Mol. Cell. Cardiol. 35 (2003) 71-80. (Pubitemid 36286969)
36. Y. Wei, L.Q. Zhao, B.Z. Qi, X. Xiao, L. He, G.Q. Zhou, S.W. Chen, H.L. Li, L. Ruan, C.T. Zhang, S.W. Liu, Lysophosphatidic acid increases the electrophysiological instability of adult rabbit ventricular myocardium by augmenting L-type calcium current, PLoS One 7 (2012) e45862.
37. J.S. Karliner, N. Honbo, K. Summers, M.O. Gray, E.J. Goetzl, The lysophospholipids sphingosine-1-phosphate and lysophosphatidic acid enhance survival during hypoxia in neonatal rat cardiac myocytes, J. Mol. Cell. Cardiol. 33 (2001) 1713-1717. (Pubitemid 32844228)
38. R. Hilal-Dandan, C.K. Means, A.B. Gustafsson, M.R. Morissette, J.W. Adams, L.L. Brunton, J. Heller Brown, Lysophosphatidic acid induces hypertrophy of neonatal cardiac myocytes via activation of Gi and Rho, J. Mol. Cell. Cardiol. 36 (2004) 481-493. (Pubitemid 38469939)
39. J. Wang, R. Xu, F. Lin, S. Zhang, G. Zhang, S. Hu, Z. Zheng, MicroRNA: novel regulators involved in the remodeling and reverse remodeling of the heart, Cardiology 113 (2009) 81-88.